nodes	percent_of_prediction	percent_of_DWPC	metapath
Dantrolene—CYP3A4—Tamoxifen—pancreatic cancer	0.0378	0.24	CbGbCtD
Dantrolene—CYP3A4—Erlotinib—pancreatic cancer	0.0322	0.204	CbGbCtD
Dantrolene—CYP3A4—Irinotecan—pancreatic cancer	0.029	0.185	CbGbCtD
Dantrolene—CYP3A4—Docetaxel—pancreatic cancer	0.0213	0.135	CbGbCtD
Dantrolene—CYP3A4—Sunitinib—pancreatic cancer	0.0212	0.135	CbGbCtD
Dantrolene—CYP3A4—Doxorubicin—pancreatic cancer	0.0159	0.101	CbGbCtD
Dantrolene—Abdominal pain—Sunitinib—pancreatic cancer	0.00131	0.00155	CcSEcCtD
Dantrolene—Body temperature increased—Sunitinib—pancreatic cancer	0.00131	0.00155	CcSEcCtD
Dantrolene—Diarrhoea—Erlotinib—pancreatic cancer	0.00131	0.00155	CcSEcCtD
Dantrolene—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00131	0.00155	CcSEcCtD
Dantrolene—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.0013	0.00155	CcSEcCtD
Dantrolene—Anorexia—Irinotecan—pancreatic cancer	0.0013	0.00154	CcSEcCtD
Dantrolene—Gastrointestinal haemorrhage—Epirubicin—pancreatic cancer	0.0013	0.00154	CcSEcCtD
Dantrolene—Diplopia—Epirubicin—pancreatic cancer	0.0013	0.00154	CcSEcCtD
Dantrolene—Pain in extremity—Epirubicin—pancreatic cancer	0.0013	0.00154	CcSEcCtD
Dantrolene—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00129	0.00153	CcSEcCtD
Dantrolene—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00128	0.00152	CcSEcCtD
Dantrolene—Visual impairment—Docetaxel—pancreatic cancer	0.00128	0.00152	CcSEcCtD
Dantrolene—Dizziness—Tamoxifen—pancreatic cancer	0.00128	0.00152	CcSEcCtD
Dantrolene—Tachycardia—Fluorouracil—pancreatic cancer	0.00128	0.00151	CcSEcCtD
Dantrolene—Anorexia—Gemcitabine—pancreatic cancer	0.00127	0.0015	CcSEcCtD
Dantrolene—Dizziness—Erlotinib—pancreatic cancer	0.00127	0.0015	CcSEcCtD
Dantrolene—Anorexia—Fluorouracil—pancreatic cancer	0.00125	0.00148	CcSEcCtD
Dantrolene—Insomnia—Irinotecan—pancreatic cancer	0.00123	0.00147	CcSEcCtD
Dantrolene—Flushing—Docetaxel—pancreatic cancer	0.00123	0.00146	CcSEcCtD
Dantrolene—Vomiting—Tamoxifen—pancreatic cancer	0.00123	0.00146	CcSEcCtD
Dantrolene—Cardiac failure—Doxorubicin—pancreatic cancer	0.00123	0.00146	CcSEcCtD
Dantrolene—Hypersensitivity—Sunitinib—pancreatic cancer	0.00122	0.00145	CcSEcCtD
Dantrolene—Rash—Tamoxifen—pancreatic cancer	0.00122	0.00145	CcSEcCtD
Dantrolene—Dermatitis—Tamoxifen—pancreatic cancer	0.00122	0.00145	CcSEcCtD
Dantrolene—Vomiting—Erlotinib—pancreatic cancer	0.00122	0.00144	CcSEcCtD
Dantrolene—Somnolence—Irinotecan—pancreatic cancer	0.00121	0.00144	CcSEcCtD
Dantrolene—Headache—Tamoxifen—pancreatic cancer	0.00121	0.00144	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00121	0.00144	CcSEcCtD
Dantrolene—Rash—Erlotinib—pancreatic cancer	0.00121	0.00143	CcSEcCtD
Dantrolene—Dermatitis—Erlotinib—pancreatic cancer	0.00121	0.00143	CcSEcCtD
Dantrolene—Insomnia—Gemcitabine—pancreatic cancer	0.0012	0.00143	CcSEcCtD
Dantrolene—Dyspepsia—Irinotecan—pancreatic cancer	0.0012	0.00143	CcSEcCtD
Dantrolene—Headache—Erlotinib—pancreatic cancer	0.0012	0.00142	CcSEcCtD
Dantrolene—Pain in extremity—Doxorubicin—pancreatic cancer	0.0012	0.00142	CcSEcCtD
Dantrolene—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.0012	0.00142	CcSEcCtD
Dantrolene—Diplopia—Doxorubicin—pancreatic cancer	0.0012	0.00142	CcSEcCtD
Dantrolene—Chills—Docetaxel—pancreatic cancer	0.00119	0.00141	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00119	0.00141	CcSEcCtD
Dantrolene—Asthenia—Sunitinib—pancreatic cancer	0.00119	0.00141	CcSEcCtD
Dantrolene—Decreased appetite—Irinotecan—pancreatic cancer	0.00119	0.00141	CcSEcCtD
Dantrolene—Insomnia—Fluorouracil—pancreatic cancer	0.00118	0.0014	CcSEcCtD
Dantrolene—Somnolence—Gemcitabine—pancreatic cancer	0.00118	0.0014	CcSEcCtD
Dantrolene—Fatigue—Irinotecan—pancreatic cancer	0.00118	0.0014	CcSEcCtD
Dantrolene—Pruritus—Sunitinib—pancreatic cancer	0.00117	0.00139	CcSEcCtD
Dantrolene—Constipation—Irinotecan—pancreatic cancer	0.00117	0.00139	CcSEcCtD
Dantrolene—Pain—Irinotecan—pancreatic cancer	0.00117	0.00139	CcSEcCtD
Dantrolene—Somnolence—Fluorouracil—pancreatic cancer	0.00116	0.00138	CcSEcCtD
Dantrolene—Erythema—Docetaxel—pancreatic cancer	0.00116	0.00137	CcSEcCtD
Dantrolene—Decreased appetite—Gemcitabine—pancreatic cancer	0.00116	0.00137	CcSEcCtD
Dantrolene—Dyspepsia—Fluorouracil—pancreatic cancer	0.00115	0.00137	CcSEcCtD
Dantrolene—Nausea—Tamoxifen—pancreatic cancer	0.00115	0.00136	CcSEcCtD
Dantrolene—Fatigue—Gemcitabine—pancreatic cancer	0.00115	0.00136	CcSEcCtD
Dantrolene—Muscular weakness—Epirubicin—pancreatic cancer	0.00114	0.00136	CcSEcCtD
Dantrolene—Pain—Gemcitabine—pancreatic cancer	0.00114	0.00135	CcSEcCtD
Dantrolene—Constipation—Gemcitabine—pancreatic cancer	0.00114	0.00135	CcSEcCtD
Dantrolene—Nausea—Erlotinib—pancreatic cancer	0.00114	0.00135	CcSEcCtD
Dantrolene—Decreased appetite—Fluorouracil—pancreatic cancer	0.00114	0.00135	CcSEcCtD
Dantrolene—Diarrhoea—Sunitinib—pancreatic cancer	0.00113	0.00135	CcSEcCtD
Dantrolene—Dysgeusia—Docetaxel—pancreatic cancer	0.00113	0.00134	CcSEcCtD
Dantrolene—Feeling abnormal—Irinotecan—pancreatic cancer	0.00112	0.00134	CcSEcCtD
Dantrolene—Dysphagia—Epirubicin—pancreatic cancer	0.00112	0.00133	CcSEcCtD
Dantrolene—Back pain—Docetaxel—pancreatic cancer	0.00112	0.00133	CcSEcCtD
Dantrolene—Pain—Fluorouracil—pancreatic cancer	0.00112	0.00133	CcSEcCtD
Dantrolene—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00112	0.00132	CcSEcCtD
Dantrolene—Eosinophilia—Epirubicin—pancreatic cancer	0.00111	0.00132	CcSEcCtD
Dantrolene—Dizziness—Sunitinib—pancreatic cancer	0.0011	0.0013	CcSEcCtD
Dantrolene—Feeling abnormal—Gemcitabine—pancreatic cancer	0.0011	0.0013	CcSEcCtD
Dantrolene—Abdominal pain—Irinotecan—pancreatic cancer	0.00108	0.00128	CcSEcCtD
Dantrolene—Body temperature increased—Irinotecan—pancreatic cancer	0.00108	0.00128	CcSEcCtD
Dantrolene—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00108	0.00128	CcSEcCtD
Dantrolene—Anaemia—Docetaxel—pancreatic cancer	0.00107	0.00127	CcSEcCtD
Dantrolene—Muscular weakness—Doxorubicin—pancreatic cancer	0.00106	0.00125	CcSEcCtD
Dantrolene—Vomiting—Sunitinib—pancreatic cancer	0.00105	0.00125	CcSEcCtD
Dantrolene—Body temperature increased—Gemcitabine—pancreatic cancer	0.00105	0.00125	CcSEcCtD
Dantrolene—Rash—Sunitinib—pancreatic cancer	0.00104	0.00124	CcSEcCtD
Dantrolene—Dermatitis—Sunitinib—pancreatic cancer	0.00104	0.00124	CcSEcCtD
Dantrolene—Urticaria—Fluorouracil—pancreatic cancer	0.00104	0.00123	CcSEcCtD
Dantrolene—Headache—Sunitinib—pancreatic cancer	0.00104	0.00123	CcSEcCtD
Dantrolene—Dysphagia—Doxorubicin—pancreatic cancer	0.00104	0.00123	CcSEcCtD
Dantrolene—Leukopenia—Docetaxel—pancreatic cancer	0.00104	0.00123	CcSEcCtD
Dantrolene—Pollakiuria—Epirubicin—pancreatic cancer	0.00103	0.00123	CcSEcCtD
Dantrolene—Body temperature increased—Fluorouracil—pancreatic cancer	0.00103	0.00123	CcSEcCtD
Dantrolene—Eosinophilia—Doxorubicin—pancreatic cancer	0.00103	0.00122	CcSEcCtD
Dantrolene—Hypersensitivity—Irinotecan—pancreatic cancer	0.00101	0.00119	CcSEcCtD
Dantrolene—Convulsion—Docetaxel—pancreatic cancer	0.001	0.00119	CcSEcCtD
Dantrolene—Hypertension—Docetaxel—pancreatic cancer	0.000998	0.00118	CcSEcCtD
Dantrolene—Drowsiness—Epirubicin—pancreatic cancer	0.000998	0.00118	CcSEcCtD
Dantrolene—Myalgia—Docetaxel—pancreatic cancer	0.000984	0.00117	CcSEcCtD
Dantrolene—Nausea—Sunitinib—pancreatic cancer	0.000984	0.00117	CcSEcCtD
Dantrolene—Renal failure—Epirubicin—pancreatic cancer	0.000981	0.00116	CcSEcCtD
Dantrolene—Asthenia—Irinotecan—pancreatic cancer	0.000979	0.00116	CcSEcCtD
Dantrolene—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000963	0.00114	CcSEcCtD
Dantrolene—Dry mouth—Docetaxel—pancreatic cancer	0.000963	0.00114	CcSEcCtD
Dantrolene—Sweating—Epirubicin—pancreatic cancer	0.000957	0.00114	CcSEcCtD
Dantrolene—Pollakiuria—Doxorubicin—pancreatic cancer	0.000957	0.00114	CcSEcCtD
Dantrolene—Asthenia—Gemcitabine—pancreatic cancer	0.000954	0.00113	CcSEcCtD
Dantrolene—Haematuria—Epirubicin—pancreatic cancer	0.000952	0.00113	CcSEcCtD
Dantrolene—Confusional state—Docetaxel—pancreatic cancer	0.000952	0.00113	CcSEcCtD
Dantrolene—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000944	0.00112	CcSEcCtD
Dantrolene—Pruritus—Gemcitabine—pancreatic cancer	0.000941	0.00112	CcSEcCtD
Dantrolene—Diarrhoea—Irinotecan—pancreatic cancer	0.000934	0.00111	CcSEcCtD
Dantrolene—Pruritus—Fluorouracil—pancreatic cancer	0.000925	0.0011	CcSEcCtD
Dantrolene—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000924	0.0011	CcSEcCtD
Dantrolene—Drowsiness—Doxorubicin—pancreatic cancer	0.000923	0.0011	CcSEcCtD
Dantrolene—Tachycardia—Docetaxel—pancreatic cancer	0.000921	0.00109	CcSEcCtD
Dantrolene—Diarrhoea—Gemcitabine—pancreatic cancer	0.00091	0.00108	CcSEcCtD
Dantrolene—Renal failure—Doxorubicin—pancreatic cancer	0.000908	0.00108	CcSEcCtD
Dantrolene—Dizziness—Irinotecan—pancreatic cancer	0.000903	0.00107	CcSEcCtD
Dantrolene—Haemoglobin—Epirubicin—pancreatic cancer	0.0009	0.00107	CcSEcCtD
Dantrolene—Anorexia—Docetaxel—pancreatic cancer	0.0009	0.00107	CcSEcCtD
Dantrolene—Hepatitis—Epirubicin—pancreatic cancer	0.000896	0.00106	CcSEcCtD
Dantrolene—Haemorrhage—Epirubicin—pancreatic cancer	0.000896	0.00106	CcSEcCtD
Dantrolene—Diarrhoea—Fluorouracil—pancreatic cancer	0.000895	0.00106	CcSEcCtD
Dantrolene—Sweating—Doxorubicin—pancreatic cancer	0.000885	0.00105	CcSEcCtD
Dantrolene—Haematuria—Doxorubicin—pancreatic cancer	0.00088	0.00104	CcSEcCtD
Dantrolene—Vomiting—Irinotecan—pancreatic cancer	0.000868	0.00103	CcSEcCtD
Dantrolene—Dizziness—Fluorouracil—pancreatic cancer	0.000865	0.00103	CcSEcCtD
Dantrolene—Visual impairment—Epirubicin—pancreatic cancer	0.000863	0.00102	CcSEcCtD
Dantrolene—Rash—Irinotecan—pancreatic cancer	0.000861	0.00102	CcSEcCtD
Dantrolene—Dermatitis—Irinotecan—pancreatic cancer	0.00086	0.00102	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00086	0.00102	CcSEcCtD
Dantrolene—Headache—Irinotecan—pancreatic cancer	0.000855	0.00101	CcSEcCtD
Dantrolene—Insomnia—Docetaxel—pancreatic cancer	0.000854	0.00101	CcSEcCtD
Dantrolene—Vomiting—Gemcitabine—pancreatic cancer	0.000845	0.001	CcSEcCtD
Dantrolene—Somnolence—Docetaxel—pancreatic cancer	0.000839	0.000996	CcSEcCtD
Dantrolene—Rash—Gemcitabine—pancreatic cancer	0.000838	0.000995	CcSEcCtD
Dantrolene—Dermatitis—Gemcitabine—pancreatic cancer	0.000838	0.000994	CcSEcCtD
Dantrolene—Haemoglobin—Doxorubicin—pancreatic cancer	0.000833	0.000989	CcSEcCtD
Dantrolene—Headache—Gemcitabine—pancreatic cancer	0.000833	0.000989	CcSEcCtD
Dantrolene—Flushing—Epirubicin—pancreatic cancer	0.000831	0.000987	CcSEcCtD
Dantrolene—Vomiting—Fluorouracil—pancreatic cancer	0.000831	0.000987	CcSEcCtD
Dantrolene—Dyspepsia—Docetaxel—pancreatic cancer	0.000831	0.000986	CcSEcCtD
Dantrolene—Hepatitis—Doxorubicin—pancreatic cancer	0.000829	0.000984	CcSEcCtD
Dantrolene—Haemorrhage—Doxorubicin—pancreatic cancer	0.000829	0.000984	CcSEcCtD
Dantrolene—Rash—Fluorouracil—pancreatic cancer	0.000824	0.000978	CcSEcCtD
Dantrolene—Dermatitis—Fluorouracil—pancreatic cancer	0.000824	0.000977	CcSEcCtD
Dantrolene—Decreased appetite—Docetaxel—pancreatic cancer	0.00082	0.000974	CcSEcCtD
Dantrolene—Headache—Fluorouracil—pancreatic cancer	0.000819	0.000972	CcSEcCtD
Dantrolene—Fatigue—Docetaxel—pancreatic cancer	0.000814	0.000966	CcSEcCtD
Dantrolene—Nausea—Irinotecan—pancreatic cancer	0.000811	0.000962	CcSEcCtD
Dantrolene—Pain—Docetaxel—pancreatic cancer	0.000807	0.000958	CcSEcCtD
Dantrolene—Constipation—Docetaxel—pancreatic cancer	0.000807	0.000958	CcSEcCtD
Dantrolene—Chills—Epirubicin—pancreatic cancer	0.000804	0.000954	CcSEcCtD
Dantrolene—Visual impairment—Doxorubicin—pancreatic cancer	0.000799	0.000948	CcSEcCtD
Dantrolene—Nausea—Gemcitabine—pancreatic cancer	0.00079	0.000937	CcSEcCtD
Dantrolene—Erythema—Epirubicin—pancreatic cancer	0.00078	0.000926	CcSEcCtD
Dantrolene—Feeling abnormal—Docetaxel—pancreatic cancer	0.000778	0.000923	CcSEcCtD
Dantrolene—Nausea—Fluorouracil—pancreatic cancer	0.000777	0.000922	CcSEcCtD
Dantrolene—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000772	0.000916	CcSEcCtD
Dantrolene—Flushing—Doxorubicin—pancreatic cancer	0.000769	0.000913	CcSEcCtD
Dantrolene—Tension—Epirubicin—pancreatic cancer	0.000765	0.000908	CcSEcCtD
Dantrolene—Dysgeusia—Epirubicin—pancreatic cancer	0.000764	0.000906	CcSEcCtD
Dantrolene—Nervousness—Epirubicin—pancreatic cancer	0.000757	0.000899	CcSEcCtD
Dantrolene—Back pain—Epirubicin—pancreatic cancer	0.000754	0.000895	CcSEcCtD
Dantrolene—Abdominal pain—Docetaxel—pancreatic cancer	0.000746	0.000885	CcSEcCtD
Dantrolene—Body temperature increased—Docetaxel—pancreatic cancer	0.000746	0.000885	CcSEcCtD
Dantrolene—Chills—Doxorubicin—pancreatic cancer	0.000744	0.000883	CcSEcCtD
Dantrolene—Vision blurred—Epirubicin—pancreatic cancer	0.000735	0.000872	CcSEcCtD
Dantrolene—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000724	0.000859	CcSEcCtD
Dantrolene—Erythema—Doxorubicin—pancreatic cancer	0.000722	0.000856	CcSEcCtD
Dantrolene—Anaemia—Epirubicin—pancreatic cancer	0.000721	0.000855	CcSEcCtD
Dantrolene—Tension—Doxorubicin—pancreatic cancer	0.000708	0.00084	CcSEcCtD
Dantrolene—Dysgeusia—Doxorubicin—pancreatic cancer	0.000707	0.000839	CcSEcCtD
Dantrolene—Malaise—Epirubicin—pancreatic cancer	0.000703	0.000835	CcSEcCtD
Dantrolene—Nervousness—Doxorubicin—pancreatic cancer	0.000701	0.000832	CcSEcCtD
Dantrolene—Leukopenia—Epirubicin—pancreatic cancer	0.000698	0.000828	CcSEcCtD
Dantrolene—Back pain—Doxorubicin—pancreatic cancer	0.000698	0.000828	CcSEcCtD
Dantrolene—Hypersensitivity—Docetaxel—pancreatic cancer	0.000695	0.000825	CcSEcCtD
Dantrolene—Vision blurred—Doxorubicin—pancreatic cancer	0.00068	0.000807	CcSEcCtD
Dantrolene—Asthenia—Docetaxel—pancreatic cancer	0.000677	0.000804	CcSEcCtD
Dantrolene—Convulsion—Epirubicin—pancreatic cancer	0.000676	0.000802	CcSEcCtD
Dantrolene—Hypertension—Epirubicin—pancreatic cancer	0.000673	0.000799	CcSEcCtD
Dantrolene—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.00067	0.000795	CcSEcCtD
Dantrolene—Pruritus—Docetaxel—pancreatic cancer	0.000668	0.000792	CcSEcCtD
Dantrolene—Anaemia—Doxorubicin—pancreatic cancer	0.000667	0.000792	CcSEcCtD
Dantrolene—Myalgia—Epirubicin—pancreatic cancer	0.000664	0.000788	CcSEcCtD
Dantrolene—Discomfort—Epirubicin—pancreatic cancer	0.000656	0.000779	CcSEcCtD
Dantrolene—Malaise—Doxorubicin—pancreatic cancer	0.000651	0.000772	CcSEcCtD
Dantrolene—Dry mouth—Epirubicin—pancreatic cancer	0.000649	0.000771	CcSEcCtD
Dantrolene—Leukopenia—Doxorubicin—pancreatic cancer	0.000646	0.000767	CcSEcCtD
Dantrolene—Diarrhoea—Docetaxel—pancreatic cancer	0.000646	0.000766	CcSEcCtD
Dantrolene—Confusional state—Epirubicin—pancreatic cancer	0.000642	0.000762	CcSEcCtD
Dantrolene—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000637	0.000755	CcSEcCtD
Dantrolene—Convulsion—Doxorubicin—pancreatic cancer	0.000625	0.000742	CcSEcCtD
Dantrolene—Dizziness—Docetaxel—pancreatic cancer	0.000624	0.000741	CcSEcCtD
Dantrolene—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000623	0.00074	CcSEcCtD
Dantrolene—Hypertension—Doxorubicin—pancreatic cancer	0.000623	0.000739	CcSEcCtD
Dantrolene—Tachycardia—Epirubicin—pancreatic cancer	0.000621	0.000737	CcSEcCtD
Dantrolene—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000615	0.00073	CcSEcCtD
Dantrolene—Myalgia—Doxorubicin—pancreatic cancer	0.000614	0.000729	CcSEcCtD
Dantrolene—Discomfort—Doxorubicin—pancreatic cancer	0.000607	0.00072	CcSEcCtD
Dantrolene—Anorexia—Epirubicin—pancreatic cancer	0.000607	0.00072	CcSEcCtD
Dantrolene—Dry mouth—Doxorubicin—pancreatic cancer	0.000601	0.000713	CcSEcCtD
Dantrolene—Vomiting—Docetaxel—pancreatic cancer	0.0006	0.000712	CcSEcCtD
Dantrolene—Rash—Docetaxel—pancreatic cancer	0.000595	0.000706	CcSEcCtD
Dantrolene—Dermatitis—Docetaxel—pancreatic cancer	0.000594	0.000705	CcSEcCtD
Dantrolene—Confusional state—Doxorubicin—pancreatic cancer	0.000594	0.000705	CcSEcCtD
Dantrolene—Headache—Docetaxel—pancreatic cancer	0.000591	0.000702	CcSEcCtD
Dantrolene—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000589	0.000699	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.00058	0.000688	CcSEcCtD
Dantrolene—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000577	0.000684	CcSEcCtD
Dantrolene—Insomnia—Epirubicin—pancreatic cancer	0.000576	0.000683	CcSEcCtD
Dantrolene—Tachycardia—Doxorubicin—pancreatic cancer	0.000575	0.000682	CcSEcCtD
Dantrolene—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000569	0.000676	CcSEcCtD
Dantrolene—Somnolence—Epirubicin—pancreatic cancer	0.000566	0.000672	CcSEcCtD
Dantrolene—Anorexia—Doxorubicin—pancreatic cancer	0.000561	0.000666	CcSEcCtD
Dantrolene—Nausea—Docetaxel—pancreatic cancer	0.000561	0.000665	CcSEcCtD
Dantrolene—Dyspepsia—Epirubicin—pancreatic cancer	0.00056	0.000665	CcSEcCtD
Dantrolene—Decreased appetite—Epirubicin—pancreatic cancer	0.000553	0.000657	CcSEcCtD
Dantrolene—Fatigue—Epirubicin—pancreatic cancer	0.000549	0.000651	CcSEcCtD
Dantrolene—Pain—Epirubicin—pancreatic cancer	0.000544	0.000646	CcSEcCtD
Dantrolene—Constipation—Epirubicin—pancreatic cancer	0.000544	0.000646	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000537	0.000637	CcSEcCtD
Dantrolene—Insomnia—Doxorubicin—pancreatic cancer	0.000533	0.000632	CcSEcCtD
Dantrolene—Feeling abnormal—Epirubicin—pancreatic cancer	0.000525	0.000622	CcSEcCtD
Dantrolene—Somnolence—Doxorubicin—pancreatic cancer	0.000524	0.000621	CcSEcCtD
Dantrolene—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00052	0.000618	CcSEcCtD
Dantrolene—Dyspepsia—Doxorubicin—pancreatic cancer	0.000518	0.000615	CcSEcCtD
Dantrolene—Decreased appetite—Doxorubicin—pancreatic cancer	0.000512	0.000608	CcSEcCtD
Dantrolene—Fatigue—Doxorubicin—pancreatic cancer	0.000508	0.000603	CcSEcCtD
Dantrolene—Urticaria—Epirubicin—pancreatic cancer	0.000506	0.0006	CcSEcCtD
Dantrolene—Pain—Doxorubicin—pancreatic cancer	0.000504	0.000598	CcSEcCtD
Dantrolene—Constipation—Doxorubicin—pancreatic cancer	0.000504	0.000598	CcSEcCtD
Dantrolene—Body temperature increased—Epirubicin—pancreatic cancer	0.000503	0.000597	CcSEcCtD
Dantrolene—Abdominal pain—Epirubicin—pancreatic cancer	0.000503	0.000597	CcSEcCtD
Dantrolene—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000485	0.000576	CcSEcCtD
Dantrolene—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000482	0.000572	CcSEcCtD
Dantrolene—Hypersensitivity—Epirubicin—pancreatic cancer	0.000469	0.000557	CcSEcCtD
Dantrolene—Urticaria—Doxorubicin—pancreatic cancer	0.000468	0.000555	CcSEcCtD
Dantrolene—Body temperature increased—Doxorubicin—pancreatic cancer	0.000466	0.000553	CcSEcCtD
Dantrolene—Abdominal pain—Doxorubicin—pancreatic cancer	0.000466	0.000553	CcSEcCtD
Dantrolene—Asthenia—Epirubicin—pancreatic cancer	0.000457	0.000542	CcSEcCtD
Dantrolene—Pruritus—Epirubicin—pancreatic cancer	0.00045	0.000534	CcSEcCtD
Dantrolene—Diarrhoea—Epirubicin—pancreatic cancer	0.000436	0.000517	CcSEcCtD
Dantrolene—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000434	0.000515	CcSEcCtD
Dantrolene—Asthenia—Doxorubicin—pancreatic cancer	0.000423	0.000501	CcSEcCtD
Dantrolene—Dizziness—Epirubicin—pancreatic cancer	0.000421	0.0005	CcSEcCtD
Dantrolene—Pruritus—Doxorubicin—pancreatic cancer	0.000417	0.000494	CcSEcCtD
Dantrolene—Vomiting—Epirubicin—pancreatic cancer	0.000405	0.00048	CcSEcCtD
Dantrolene—Diarrhoea—Doxorubicin—pancreatic cancer	0.000403	0.000478	CcSEcCtD
Dantrolene—Rash—Epirubicin—pancreatic cancer	0.000401	0.000476	CcSEcCtD
Dantrolene—Dermatitis—Epirubicin—pancreatic cancer	0.000401	0.000476	CcSEcCtD
Dantrolene—Headache—Epirubicin—pancreatic cancer	0.000399	0.000473	CcSEcCtD
Dantrolene—Dizziness—Doxorubicin—pancreatic cancer	0.000389	0.000462	CcSEcCtD
Dantrolene—Nausea—Epirubicin—pancreatic cancer	0.000378	0.000449	CcSEcCtD
Dantrolene—Vomiting—Doxorubicin—pancreatic cancer	0.000374	0.000444	CcSEcCtD
Dantrolene—Rash—Doxorubicin—pancreatic cancer	0.000371	0.000441	CcSEcCtD
Dantrolene—Dermatitis—Doxorubicin—pancreatic cancer	0.000371	0.00044	CcSEcCtD
Dantrolene—Headache—Doxorubicin—pancreatic cancer	0.000369	0.000438	CcSEcCtD
Dantrolene—Nausea—Doxorubicin—pancreatic cancer	0.00035	0.000415	CcSEcCtD
